At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase III, Multicenter, Observer-blind, Safety and Immunogenicity Study of Rabies Vaccine and Japanese Encephalitis Vaccine Administered Concomitantly and/or Separately According to 1 of 2 Different Preexposure Prophylaxis Schedules to Healthy Adult Subjects.
In Brief
A Phase 3 clinical trial evaluating Rabies, Japanese Encephalitis, and 1 other intervention for Rabies and Japanese Encephalitis. Completed, enrolled 661 participants across 3 sites in 3 countries.
Detailed Summary
Establish non-inferiority of the immune response and evaluate the safety and tolerability of Rabies and Japanese Encephalitis (JE) vaccines given concomitantly or alone and according to either of 2 schedules for preexposure prophylaxis.
Study Details
Timeline
Interventions
Subjects received three doses of Rabies, whole virus vaccine (inactivated, Germany).
Subjects received two doses of Japanese Encephalitis vaccine.
Subjects received either two, three, four or five doses of normal saline, 0.9% w/v sodium chloride depending on the vaccine group.